Cargando…
Undifferentiated uterine sarcoma metastatic to the brain
BACKGROUND: Undifferentiated uterine sarcoma (UUS) is a rare tumor with an aggressive growth pattern. They occur in women from 40 to 60 years and are generally characterized by poor prognosis, a high rate of local recurrence, and distant metastases. UUS accounts for 0.2% of all gynecological maligna...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3815079/ https://www.ncbi.nlm.nih.gov/pubmed/24231690 http://dx.doi.org/10.4103/2152-7806.119054 |
_version_ | 1782289357836648448 |
---|---|
author | Stofko, Douglas L |
author_facet | Stofko, Douglas L |
author_sort | Stofko, Douglas L |
collection | PubMed |
description | BACKGROUND: Undifferentiated uterine sarcoma (UUS) is a rare tumor with an aggressive growth pattern. They occur in women from 40 to 60 years and are generally characterized by poor prognosis, a high rate of local recurrence, and distant metastases. UUS accounts for 0.2% of all gynecological malignancies. Possible treatments include surgery, radiotherapy, and chemotherapy. CASE DESCRIPTION: A 65-year-old female with postmenopausal bleeding was found to have a uterine mass for which she underwent a total abdominal hysterectomy, bilateral salpingo-oophorectomy, and omentectomy. The pathologic evaluation was consistent with undifferentiated endometrial sarcoma. She began experiencing headaches with associated visual disturbances. Magnetic resonance imaging (MRI) of the brain showed a homogenous enhancing occipital dural-based mass measuring 1.6 × 1.8 × 1.7 cm. Due to the rarity of metastatic uterine sarcoma to the brain, this was believed to represent a meningioma and subsequently observed. Interval MRI scan revealed a significant increase in size of the right occipital mass to 2.3 cm with increased edema and mass effect. She underwent right occipital image guided craniotomy for resection of the mass. Histopathology confirmed UUS metastases. CONCLUSION: Randomized trials analyzing these treatment options are limited due to the rarity of this disease; therefore, a standard therapy is not established. Based on a review of the literature, this is only the fourth case reported of UUS metastatic to the brain. |
format | Online Article Text |
id | pubmed-3815079 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-38150792013-11-14 Undifferentiated uterine sarcoma metastatic to the brain Stofko, Douglas L Surg Neurol Int Case Report BACKGROUND: Undifferentiated uterine sarcoma (UUS) is a rare tumor with an aggressive growth pattern. They occur in women from 40 to 60 years and are generally characterized by poor prognosis, a high rate of local recurrence, and distant metastases. UUS accounts for 0.2% of all gynecological malignancies. Possible treatments include surgery, radiotherapy, and chemotherapy. CASE DESCRIPTION: A 65-year-old female with postmenopausal bleeding was found to have a uterine mass for which she underwent a total abdominal hysterectomy, bilateral salpingo-oophorectomy, and omentectomy. The pathologic evaluation was consistent with undifferentiated endometrial sarcoma. She began experiencing headaches with associated visual disturbances. Magnetic resonance imaging (MRI) of the brain showed a homogenous enhancing occipital dural-based mass measuring 1.6 × 1.8 × 1.7 cm. Due to the rarity of metastatic uterine sarcoma to the brain, this was believed to represent a meningioma and subsequently observed. Interval MRI scan revealed a significant increase in size of the right occipital mass to 2.3 cm with increased edema and mass effect. She underwent right occipital image guided craniotomy for resection of the mass. Histopathology confirmed UUS metastases. CONCLUSION: Randomized trials analyzing these treatment options are limited due to the rarity of this disease; therefore, a standard therapy is not established. Based on a review of the literature, this is only the fourth case reported of UUS metastatic to the brain. Medknow Publications & Media Pvt Ltd 2013-09-27 /pmc/articles/PMC3815079/ /pubmed/24231690 http://dx.doi.org/10.4103/2152-7806.119054 Text en Copyright: © 2013 Stofko DL http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Case Report Stofko, Douglas L Undifferentiated uterine sarcoma metastatic to the brain |
title | Undifferentiated uterine sarcoma metastatic to the brain |
title_full | Undifferentiated uterine sarcoma metastatic to the brain |
title_fullStr | Undifferentiated uterine sarcoma metastatic to the brain |
title_full_unstemmed | Undifferentiated uterine sarcoma metastatic to the brain |
title_short | Undifferentiated uterine sarcoma metastatic to the brain |
title_sort | undifferentiated uterine sarcoma metastatic to the brain |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3815079/ https://www.ncbi.nlm.nih.gov/pubmed/24231690 http://dx.doi.org/10.4103/2152-7806.119054 |
work_keys_str_mv | AT stofkodouglasl undifferentiateduterinesarcomametastatictothebrain |